4D robust optimization in pencil beam scanning proton therapy for hepatocellular carcinoma

The treatment of moving targets is a challenging task using high conformal radiation techniques such as pencil beam scanning (PBS) proton therapy and requires adequate motion mitigation. Recent guidelines propose 4D robust optimization to mitigate motion artefacts in PBS therapy of thoracic malignancies. However, the availability of dosimetric analyses supporting this recommendation is limited and even non-existing for other tumour sites. The objective of this study was therefore to analyse the effectiveness of 4D robust optimization for hepatocellular carcinoma (HCC), representative for moving abdominal targets. These are usually less affected by uncertainties due to tissue heterogeneities than thoracic targets. 4D robustly optimized plans were compared with beam-specific margin plans for 6 HCC patients based on 4D dynamic accumulated doses (4DDD). 4DDD computations were conducted in RayStation with an experimentally validated routine including a site-specific beam time model. Contrary to expectations based on thoracic studies, 4D robust optimization did not yield a more homogeneous target coverage except for shallow targets close to the ribs. A clear advantage of 4D robust optimization is the sparing of normal tissue. The average dose to the normal liver could be reduced by up to 12%.

[1]  James Shackleford,et al.  Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer. , 2013, International journal of radiation oncology, biology, physics.

[2]  Wei Liu,et al.  Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer. , 2016, International journal of radiation oncology, biology, physics.

[3]  Stina Svensson,et al.  The ANACONDA algorithm for deformable image registration in radiotherapy. , 2014, Medical physics.

[4]  T. Hashimoto,et al.  Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma , 2013, Acta oncologica.

[5]  C Bert,et al.  Motion in radiotherapy: particle therapy , 2011, Physics in medicine and biology.

[6]  J. Slater,et al.  The safety and efficacy of high‐dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial , 2011, Cancer.

[7]  Li Liao,et al.  Motion-robust intensity-modulated proton therapy for distal esophageal cancer. , 2016, Medical physics.

[8]  Oliver Blanck,et al.  Lipiodol versus diaphragm in 4D-CBCT-guided stereotactic radiotherapy of hepatocellular carcinomas , 2016, Strahlentherapie und Onkologie.

[9]  Wei Liu,et al.  Consensus Guidelines for Implementing Pencil-Beam Scanning Proton Therapy for Thoracic Malignancies on Behalf of the PTCOG Thoracic and Lymphoma Subcommittee. , 2017, International journal of radiation oncology, biology, physics.

[10]  Beate Timmermann,et al.  Experimental validation of a 4D dose calculation routine for pencil beam scanning proton therapy. , 2017, Zeitschrift fur medizinische Physik.